Expression of abelson interactor 1 (Abi1) correlates with inflammation, kras mutation and adenomatous change during colonic carcinogenesis

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Steinestel, Konrad ^a,b   Brüderlein, Silke ^a   Steinestel, Julie ^a   Märkl, Bruno ^c   Schwerer, Michael J ^d   Arndt, Annette ^b   Kraft, Klaus ^b   Pröpper, Christian ^a   Möller, Peter ^a  

^a UNIVERSITY OF ULM   (Germany)

^b Bundeswehrkrankenhaus Ulm ^*  (Germany)

^c KLINIKUM AUGSBURG   (Germany)

^d German Air Force Institute of Aviation Medicine   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON INTERACTOR 1; ACTIN; ADAPTOR PROTEIN; B RAF KINASE; K RAS PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; WORTMANNIN;

ADENOMATOUS POLYP; ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CELL STIMULATION; COLITIS; COLON ADENOMA; COLON CARCINOGENESIS; COLON METASTASIS; COLON MUCOSA; COLON POLYP; COLORECTAL CARCINOMA; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; ONCOGENE K RAS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RECTUM ADENOMA; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; WILD TYPE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOMA; AGED; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; CYTOSKELETAL PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTESTINAL MUCOSA; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MUTATION; NEOPLASM METASTASIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84863635262     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040671     Document Type: Article

References (53)

1. Thomas DB, Karagas MR, (1987) Cancer in first and second generation Americans. Cancer Res 47: 5771.
2. Aaltonen LA, Peltomäki P, Leach FS, Sistonen P, Pylkkänen L, (1993) Clues to the pathogenesis of familial colorectal cancer. Science 260: 812-816.
3. Huang EH, Wicha MS, (2008) Colon cancer stem cells: implications for prevention and therapy. Trends Mol Med 17(11): 503-9.
4. Snover DC, (2011) Update on the serrated pathway to colorectal carcinoma. Hum Pathol. 42(1): 1-10.
5. Leggett B, Whitehall V, (2010) Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 138(6): 2088-100.
6. Noffsinger AE, (2009) Serrated polyps and colorectal cancer: new pathway to malignancy. Annu Rev Pathol 4: 343-64.
7. Gay F, Estornes Y, Saurin JC, Joly-Pharaboz MO, Friederich E, et al. (2008) In colon carcinogenesis, the cytoskeletal protein gelsolin is down-regulated during the transition from adenoma to carcinoma. Hum Pathol 39(10): 1420-30.
8. Kheir WA, Gevrey JC, Yamaguchi H, Isaac B, Cox D, (2005) A WAVE2-Abi1 complex mediates CSF-1-induced F-actin-rich membrane protrusions and migration in macrophages. J Cell Sci 118: 5369-79.
9. Steffen A, Rottner K, Ehinger J, Innocenti M, Scita G, et al. (2004) Sra-1 and Nap1 link rac to actin assembly driving lamellipodia formation. EMBO J 23: 749-59.
10. Innocenti M, Frittoli E, Ponzanelli I, Falck JR, Brachmann SM, et al. (2003) Phosphoinositide 3-kinase activates Rac by entering in a complex with Eps8, Abi1, and Sos-1. J Cell Biol 160(1): 17-23.
11. Stradal T, Courtney KD, Rottner K, Hahne P, Small JV, et al. (2001) The abl interactor proteins localize to sites of actin polymerization at the tips of lamellipodia and filopodia. Curr Biol 11: 891-5.
12. Proepper C, Johannsen S, Liebau S, Dahl J, Vaida B, et al. (2007) Abelson interacting protein 1 (Abi-1) is essential for dendrite morphogenesis and synapse formation. EMBO J 26(5): 1397-409.
13. Liebau S, Steinestel J, Linta L, Kleger A, Storch A, et al. (2011) An SK3 channel/nWASP/Abi-1 complex is involved in early neurogenesis. PLoS One 6(3): e18148.
14. Yu W, Sun X, Clough N, Cobos E, Tao Y, et al. (2008) Abi1 gene silencing by short hairpin RNA impairs Bcr-Abl-induced cell adhesion and migration in vitro and leukemogenesis in vivo. Carcinogenesis 29(9): 1717-24.
15. Wang C, Navab R, Iakovlev V, Leng Y, Zhang J, et al. (2007) Abelson interactor protein-1 positively regulates breast cancer cell proliferation, migration, and invasion. Mol Cancer Res 5(10): 1031-9.
16. Proepper C, Steinestel K, Schmeisser MJ, Heinrich J, Steinestel J, et al. (2011) Heterogeneous nuclear ribonucleoprotein K interacts with Abi-1 at postsynaptic sites and modulates dendritic spine morphology. PLoS One 6(11): e27045.
17. Carpenter B, McKay M, Dundas SR, Lawrie LC, Telfer C, et al. (2006) Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer. Br J Cancer 95, 921-927.
18. Möller P, Koretz K, Leithäuser F, Brüderlein S, Henne C, et al. (1994) Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium. Int J Cancer 57(3): 371-7.
19. Koretz K, Brderlein S, Henne C, Fietz T, Laqu M,et al. (1994) Comparative Evaluation of Integrin Alpha- and Beta-chain Expression in Colorectal Carcinoma Cell Lines and in their Tumours of Origin.Virchows Arch 425(3):22936.
20. Schmiegel W, Pox C, Arnold D, Porschen R, Rödel C, et al. (2009) Colorectal carcinoma: the management of polyps, (neo) adjuvant therapy, and the treatment of metastases. Dtsch Arztebl Int 106(51-52): 843-8.
21. O'Brien MJ, Yang S, Mack C, Xu H, Huang CS, et al. (2006) Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol 30(12): 1491-501.
22. Kim KM, Lee EJ, Ha S, Kang SY, Jang KT, et al. (2011) Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma/polyps from Korea. Am J Surg Pathol 35(9): 1274-86.
23. Fujita K, Yamamoto H, Matsumoto T, Hirahashi M, Gushima M, et al. (2011) Sessile serrated adenoma with early neoplastic progression: a clinicopathologic and molecular study. Am J Surg Pathol 35(2): 295-304.
24. Kim KM, Lee EJ, Kim YH, Chang DK, Odze RD, (2011) KRAS mutations in traditional serrated adenomas from Korea herald an aggressive phenotype. Am J Surg Pathol 34(5): 667-75.
25. Jass JR, Baker K, Zlobec I, Higuchi T, Barker M, et al. (2006) Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer. Histopathology 49(2): 121-31.
26. Neumann J, Zeindl-Eberhart E, Kirchner T, Jung A, (2009) Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer. Pathol Res Pract 205(12): 858-62.
27. Yen LC, Uen YH, Wu DC, Lu CY, Yu FJ, et al. (2010) Activating KRAS mutations and overexpression of epidermal growth factor receptor as independent predictors in metastatic colorectal cancer patients treated with cetuximab. Ann Surg 251(2): 254-60.
28. Ring C, Ginsberg MH, Haling J, Pendergast AM, (2011) Abl-interactor-1 (Abi1) has a role in cardiovascular and placental development and is a binding partner of the alpha4 integrin. Proc Natl Acad Sci U S A 108(1): 149-54.
29. Li Y, Clough N, Sun X, Yu W, Abbott BL, et al. (2007) Bcr-Abl induces abnormal cytoskeleton remodeling, beta1 integrin clustering and increased cell adhesion to fibronectin through the Abl interactor 1 pathway. J Cell Sci 120(Pt 8): 1436-46.
30. Zipfel PA, Bunnell SC, Witherow DS, Gu JJ, Chislock EM, et al. (2006) Role for the Abi/wave protein complex in T cell receptor-mediated proliferation and cytoskeletal remodeling. Curr Biol 16(1): 35-46.
31. Feng Y, Bommer GT, Zhao J, Green M, Sands E, et al. (2011) Mutant KRAS promotes hyperplasia and alters differentiation in the colon epithelium but does not expand the presumptive stem cell pool. Gastroenterology 141(3): 1003-1013.
32. Baba RA, Bhat HF, Wani LA, Bashir M, Wani MM, et al. (2012) E3B1/ABI-1 isoforms are down-regulated in cancers of human gastrointestinal tract. Dis Markers 32(4): 273-9.
33. Henderson-Jackson EB, Helm J, Ghayouri M, Hakam A, Nasir A, et al. (2010) Correlation between Mcl-1 and pAKT protein expression in colorectal cancer. Int J Clin Exp Pathol. 3(8): 768-74.
34. Tani K, Sato S, Sukezane T, Kojima H, Hirose H, et al. (2003) Abl Interactor 1 Promotes Tyrosine 296 Phosphorylation of Mammalian Enabled (Mena) by c-Abl Kinase. J Biol Chem 278(24), 21685-92.
35. Inokuchi J, Komiya M, Baba I, Naito S, Sasazuki T, et al. (2004) Deregulated expression of KRAP, a novel gene encoding actin-interacting protein, in human colon cancer cells. J Hum Genet 49(1): 46-52.
36. Pollock CB, Shirasawa S, Sasazuki T, Kolch W, Dhillon AS, (2005) Oncogenic K-RAS is required to maintain changes in cytoskeletal organization, adhesion, and motility in colon cancer cells. Cancer Res 65(4): 1244-50.
37. Qiu RG, Chen J, Kirn D, McCormick F, Symons M, (1995) An essential role for Rac in Ras transformation. Nature 374(6521): 457-9.
38. Ridley AJ, (2001) Rho GTPases and cell migration. J Cell Sci 114: 2713-22.
39. Castellano E, Downward J, (2011) RAS Interaction with PI3K: More Than Just Another Effector Pathway. Genes Cancer 2(3): 261-74.
40. Kotula L, (2012) Abi1, a critical molecule coordinating actin cytoskeleton reorganization with PI-3 kinase and growth signaling. FEBS Lett. 2012 May 19. [Epub ahead of print].
41. Williams DL, Ozment-Skelton T, Li C, (2006) Modulation of the phosphoinositide 3-kinase signaling pathway alters host response to sepsis, inflammation, and ischemia/reperfusion injury. Shock 25(5): 432-9.
42. Chen H, Wu X, Pan ZK, Huang S, (2010) Integrity of SOS1/EPS8/ABI1 tri-complex determines ovarian cancer metastasis. Cancer Res 70(23): 9979-90.
43. Iwaya K, Oikawa K, Semba S, Tsuchiya B, Mukai Y, et al. (2007) Correlation between liver metastasis of the colocalization of actin-related protein 2 and 3 complex and WAVE2 in colorectal carcinoma. Cancer Sci 98(7): 992-9.
44. Makrodouli E, Oikonomou E, Koc M, Andera L, Sasazuki T, et al. (2011) BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study. Mol Cancer 10: 118.
45. Yilmaz M, Christofori G, (2009) EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev. 28(1-2): 15-33.
46. Leontovich AA, Zhang S, Quatraro C, Iankov I, Veroux PF, et al. (2012) Raf-1 oncogenic signaling is linked to activation of mesenchymal to epithelial transition pathway in metastatic breast cancer cells. Int J Oncol doi:10.3892/ijo.2012.1407 (Epub ahead of print).
47. Echarri A, Lai MJ, Robinson MR, Pendergast AM, (2004) Abl interactor 1 (Abi-1) wave-binding and SNARE domains regulate its nucleocytoplasmic shuttling, lamellipodium localization, and wave-1 levels. Mol Cell Biol 24(11): 4979-93.
48. de Roock W, Jonker DJ, Di Nicolantonio F, Sartore-Bianchi A, Tu D, et al. (2010) Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab. JAMA 304(16): 1812-20.
49. Miller MS, Miller LD, (2011) RAS Mutations and Oncogenesis: Not all RAS Mutations are Created Equally. Front Genet 2: 100.
50. Dundas SR, Lawrie LC, Rooney PH, Murray GI, (2005) Mortalin is over-expressed by colorectal adenocarcinomas and correlates with poor survival. J Pathol 205(1): 74-81.
51. Pikor LA, Enfield KS, Cameron H, Lam WL, (2011) DNA extraction from paraffin embedded material for genetic and epigenetic analyses. J Vis Exp 49: pii doi:10.3791/2763.
52. Monticone M, Biollo E, Maffei M, Donadini A, Romeo F, et al. (2008) Gene expression deregulation by KRAS G12D and G12V in a BRAF V600E context. Mol Cancer 7: 92.
53. German Ethics Counsil, (2010) Human Biobanks for research (Opinion). Berlin: self-published pp. 47-55.